SAMDaily.us | PRESOL | 66 | CFSAN-2023-114792--High Content Screening System.

SAMDAILY.US - ISSUE OF NOVEMBER 23, 2022 SAM #7663
SOLICITATION NOTICE

66 -- CFSAN-2023-114792--High Content Screening System.

Notice Date: 11/21/2022 4:10:01 AM
Notice Type: Combined Synopsis/Solicitation
NAICS: 334516 — Analytical Laboratory Instrument Manufacturing
Contracting Office: FDA OFFICE OF ACQ GRANT SVCS Beltsville MD 20705 USA
ZIP Code: 20705
Solicitation Number: FDA-RFQ-75F40123Q00015-CFSAN-2023-114792
Response Due: 11/30/2022 9:00:00 AM
Archive Date: 12/15/2022
Point of Contact: Emmanuel T. Mbah, Phone: 2022975333
E-Mail Address: Emmanuel.mbah@fda.hhs.gov
(Emmanuel.mbah@fda.hhs.gov)
Description: The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure a CFSAN-2023-114792-High Content Screening System, under solicitation FDA-RFQ-75F40123Q00015-CFSAN-2023-114792. The purpose of Amendment 001 is to, per attachment: Amendment 0001: i.Delete the all verbiage in the RFQ relating to PMA ii. Correct the RFQ due Date, which is 11/30/2022. Every other terms and conditions remain the same.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/7324ad6c0f204962b1d5959d57bf53d1/view)
Place of Performance: Address: MD 20708, USA; Zip Code: 20708; Country: USA
Record: SN06523560-F 20221123/221122211832 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |